Oral GLP-1 Breakthrough Expands Cardiovascular Protection Landscape for High-Risk Patients
FDA Approval Marks New Era in Cardiovascular Risk Management The pharmaceutical landscape has reached a pivotal moment with the FDA’s…
FDA Approval Marks New Era in Cardiovascular Risk Management The pharmaceutical landscape has reached a pivotal moment with the FDA’s…
Danish pharmaceutical giant Novo Nordisk has recruited American pharmaceutical veteran Greg Miley to lead global corporate affairs as the company faces mounting political pressure on drug pricing. The appointment comes during a major restructuring that includes cutting approximately 9,000 positions worldwide.
Novo Nordisk has reportedly hired former AbbVie executive Greg Miley as its new global head of corporate affairs, according to sources familiar with the matter. The appointment comes as the pharmaceutical industry faces increasing scrutiny from the Trump administration over drug pricing policies.